These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

161 related items for PubMed ID: 17531835

  • 21. The initiation of the autoimmune response in multiple sclerosis.
    Markovic-Plese S, Pinilla C, Martin R.
    Clin Neurol Neurosurg; 2004 Jun; 106(3):218-22. PubMed ID: 15177771
    [Abstract] [Full Text] [Related]

  • 22. Pathogenesis of myelin/oligodendrocyte damage in multiple sclerosis.
    Dhib-Jalbut S.
    Neurology; 2007 May 29; 68(22 Suppl 3):S13-21; discussion S43-54. PubMed ID: 17548563
    [Abstract] [Full Text] [Related]

  • 23. CD8+ T cells in inflammatory demyelinating disease.
    Weiss HA, Millward JM, Owens T.
    J Neuroimmunol; 2007 Nov 29; 191(1-2):79-85. PubMed ID: 17920696
    [Abstract] [Full Text] [Related]

  • 24. Therapeutic targeting of chemokine signaling in Multiple Sclerosis.
    Hamann I, Zipp F, Infante-Duarte C.
    J Neurol Sci; 2008 Nov 15; 274(1-2):31-8. PubMed ID: 18706659
    [Abstract] [Full Text] [Related]

  • 25. The effects of natalizumab on the innate and adaptive immune system in the central nervous system.
    Stüve O.
    J Neurol Sci; 2008 Nov 15; 274(1-2):39-41. PubMed ID: 18474372
    [Abstract] [Full Text] [Related]

  • 26. Janus faces of microglia in multiple sclerosis.
    Sanders P, De Keyser J.
    Brain Res Rev; 2007 Jun 15; 54(2):274-85. PubMed ID: 17383006
    [Abstract] [Full Text] [Related]

  • 27. The interplay between the immune and central nervous systems in neuronal injury.
    Yong VW, Marks S.
    Neurology; 2010 Jan 05; 74 Suppl 1():S9-S16. PubMed ID: 20038767
    [Abstract] [Full Text] [Related]

  • 28. Synergistic immune responses induced by endogenous retrovirus and herpesvirus antigens result in increased production of inflammatory cytokines in multiple sclerosis patients.
    Brudek T, Christensen T, Hansen HJ, Petersen T, Møller-Larsen A.
    Scand J Immunol; 2008 Mar 05; 67(3):295-303. PubMed ID: 18261041
    [Abstract] [Full Text] [Related]

  • 29. Prostaglandins in pathogenesis and treatment of multiple sclerosis.
    Mirshafiey A, Jadidi-Niaragh F.
    Immunopharmacol Immunotoxicol; 2010 Dec 05; 32(4):543-54. PubMed ID: 20233088
    [Abstract] [Full Text] [Related]

  • 30. Multiple sclerosis: a complicated picture of autoimmunity.
    McFarland HF, Martin R.
    Nat Immunol; 2007 Sep 05; 8(9):913-9. PubMed ID: 17712344
    [Abstract] [Full Text] [Related]

  • 31. CD16+ gammadelta T cells mediate antibody dependent cellular cytotoxicity: potential mechanism in the pathogenesis of multiple sclerosis.
    Chen Z, Freedman MS.
    Clin Immunol; 2008 Aug 05; 128(2):219-27. PubMed ID: 18501678
    [Abstract] [Full Text] [Related]

  • 32. Emerging roles of endothelial cells in multiple sclerosis pathophysiology and therapy.
    Minagar A, Maghzi AH, McGee JC, Alexander JS.
    Neurol Res; 2012 Oct 05; 34(8):738-45. PubMed ID: 22828184
    [Abstract] [Full Text] [Related]

  • 33. Notes on the pathogenesis of multiple sclerosis.
    Poser CM.
    Clin Neurosci; 1994 Oct 05; 2(3-4):258-65. PubMed ID: 7749896
    [Abstract] [Full Text] [Related]

  • 34. B-cell differentiation in the CNS of patients with multiple sclerosis.
    Corcione A, Aloisi F, Serafini B, Capello E, Mancardi GL, Pistoia V, Uccelli A.
    Autoimmun Rev; 2005 Nov 05; 4(8):549-54. PubMed ID: 16214094
    [Abstract] [Full Text] [Related]

  • 35. The immunology of multiple sclerosis: disease mechanisms and therapeutic targets.
    Holmøy T.
    Minerva Med; 2008 Apr 05; 99(2):119-40. PubMed ID: 18431322
    [Abstract] [Full Text] [Related]

  • 36. Neuroinflammation in multiple sclerosis: evidence for autoimmune dysregulation, not simple autoimmune reaction.
    Grigoriadis N, Grigoriadis S, Polyzoidou E, Milonas I, Karussis D.
    Clin Neurol Neurosurg; 2006 Mar 05; 108(3):241-4. PubMed ID: 16388896
    [Abstract] [Full Text] [Related]

  • 37. Antibody-secreting cells in the central nervous system in an animal model of MS: Phenotype, association with disability, and in vitro production of antibody.
    Pachner AR, Brady J, Narayan K.
    J Neuroimmunol; 2007 Oct 05; 190(1-2):112-20. PubMed ID: 17919740
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.